AZD5004 (ECC5004)

AZD5004 (ECC5004) is an agonist of GLP-1 Receptor used in studies of GPCR Signaling and Metabolic Signaling. In practice, this places the compound in experiments that measure receptor-driven second-messenger signaling and desensitization dynamics and metabolic regulation, energy sensing, and enzyme-linked homeostasis in endocrinology and metabolism models.

By activating GLP-1 Receptor, AZD5004 (ECC5004) can be used to examine receptor-driven second-messenger signaling and desensitization dynamics and metabolic regulation, energy sensing, and enzyme-linked homeostasis. The gpcr annotation adds relevance to GPCR pharmacology, ligand-binding, and signaling assays, together with downstream-response mapping in the same experimental setting. In endocrinology and metabolism models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

• Target-focused assays involving GLP-1 Receptor
• Pathway perturbation studies connected to GPCR Signaling and Metabolic Signaling
• Agonist-response and downstream signaling studies
• GPCR pharmacology, ligand-binding, and signaling assays

Overall, AZD5004 (ECC5004) is appropriate when a defined chemical perturbant is needed to connect GLP-1 Receptor with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in endocrinology and metabolism models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.